Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK

Background: Skin toxicity is a common adverse event during cetuximab (Cmab) treatment. However, few reports have investigated the correlation between skin toxicity and the efficacy of Cmab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). Methods: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Uozumi, Shinya, Enokida, Tomohiro, Suzuki, Shinya, Nishizawa, Aya, Kamata, Hayato, Okano, Tomoka, Fujisawa, Takao, Ueda, Yuri, Okano, Susumu, Tahara, Makoto, Yamaguchi, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300475/
https://www.ncbi.nlm.nih.gov/pubmed/30619755
http://dx.doi.org/10.3389/fonc.2018.00616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300475/
https://www.ncbi.nlm.nih.gov/pubmed/30619755
http://dx.doi.org/10.3389/fonc.2018.00616

Ejemplares similares